Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPT2 | P23786 | 1/20 | 0.35 |
| ▸ | CPT1A | P50416 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29780359 | 0.84 | CA4 (0.37) | CPT2CPT1ACA4SLC22A16 | |
| SCHEMBL30201053 | 0.76 | CA4 (0.41) | CPT2CPT1ACA4SLC22A16 | |
| SCHEMBL29780360 | 0.75 | SLC7A5 (0.38) | CPT2CPT1ACA4 | |
| Aspartic Acid SCHEMBL30218656 | 0.75 | GRIK1 (0.35) | CPT2CPT1ACA4SLC22A16MAPT | |
| SCHEMBL30065458 | 0.75 | CA4 (0.37) | CPT2CPT1ACA4SLC22A16 | |
| 3-Hydroxybutyric Acid, (+/-)- SCHEMBL30300556 | 0.74 | SLC22A16 (0.35) | CPT2CPT1ACA4SLC22A16MAPT | |
| SCHEMBL29623630 | 0.73 | CA4 (0.38) | CPT2CPT1ACA4SLC22A16 | |
| SCHEMBL29840028 | 0.73 | CA4 (0.38) | CPT2CPT1ACA4SLC22A16 | |
| SCHEMBL29840010 | 0.73 | CA4 (0.38) | CPT2CPT1ACA4SLC22A16 | |
| SCHEMBL29840031 | 0.73 | CA4 (0.38) | CPT2CPT1ACA4SLC22A16 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3967217-A1 | BLOOD BASED BIOMARKERS FOR DIAGNOSING ATHEROSCLEROTIC CORONARY ARTERY DISEASE | Global Genomics Group, LLC (US) | 2022-03-16 | — | — | EP | disclosed |